Linaroside
CAS No. 53452-12-3
Linaroside ( —— )
Catalog No. M24516 CAS No. 53452-12-3
Linaroside exhibited 30% inhibition for antimycobacterial activity against Mycobacterium tuberculosis, strain H(37)Rv at 6.25 microg mL(-1) concentration.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 486 | In Stock |
|
10MG | 701 | In Stock |
|
25MG | 1062 | In Stock |
|
50MG | 1458 | In Stock |
|
100MG | Get Quote | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLinaroside
-
NoteResearch use only, not for human use.
-
Brief DescriptionLinaroside exhibited 30% inhibition for antimycobacterial activity against Mycobacterium tuberculosis, strain H(37)Rv at 6.25 microg mL(-1) concentration.
-
DescriptionLinaroside exhibited 30% inhibition for antimycobacterial activity against Mycobacterium tuberculosis, strain H(37)Rv at 6.25 microg mL(-1) concentration.
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorAntimycobacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number53452-12-3
-
Formula Weight476.4
-
Molecular FormulaC23H24O11
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOc(cc1)ccc1C(Oc(c1c2O)cc(O[C@@H]([C@@H]([C@H]3O)O)O[C@H](CO)[C@H]3O)c2OC)=CC1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Begum S, et al. Antimycobacterial activity of flavonoids from Lantana camara Linn. Nat Prod Res. 2008 Apr 15;22(6):467-70.
molnova catalog
related products
-
CB-618 sodium salt
CB-618 (CB 238618) is a novel non-β-lactam β-lactamase inhibitor that potentiates meropenem MIC values against clinical Enterobacteriaceae isolates.
-
3-Chloro-L-alanine
3-Chloro-L-alanine is a bacteriostatic amino acid analog which inhibits a number of enzymes including threonine deaminase and alanine racemase.
-
Cefixime
Cefixime, an antibiotic, is a third-generation cephalosporin like ceftriaxone and cefotaxime.